Transcription of the retinoic acid receptor 2 (RAR2) gene is induced by retinoic acid (RA) in mouse P19 embryonal carcinoma (EC) cells. Here we studied RA-induced chromatin structure alterations in the endogenous RAR2 promoter and in an integrated, multicopy RAR2 promoter in EC cells. RA markedly increased restriction site accessibility within the promoter, including a site near the RA responsive element (RARE) to which the nuclear receptor retinoid X receptor (RXR)-RAR heterodimer binds. These changes coincided with RA-induced alterations in the DNase I hypersensitivity pattern in and around the promoter. These changes became undetectable upon removal of RA, which coincided with the extinction of transcription. Analyses with receptor-selective ligands and an antagonist showed that increase in restriction site accessibility correlates with transcriptional activation, which parallels the RA-induced in vivo footprint of the promoter. Despite these changes, the micrococcal nuclease digestion profile of this promoter was not altered by RA. These results indicate that concurrent with the binding of the RXR-RAR heterodimer to the RARE, the local chromatin structure undergoes dynamic, reversible changes in and around the promoter without globally affecting the nucleosomal organization.It has been shown that retinoic acid (RA) induces expression of many genes in different cell types, while repressing expression of other genes (14, 34). One of the immediate-early genes induced in P19 embryonal carcinoma (EC) cells by RA is the retinoic acid receptor 2 (RAR2) gene (49, 64). The promoter region of this gene contains an RA responsive element (RARE) to which the nuclear hormone receptor heterodimer RAR-retinoid X receptor (RXR) binds (14, 34). Previous in vivo footprinting analyses showed that the RAR2 promoter is not occupied in P19 cells prior to RA addition, but after RA addition, occupancy is induced in the RARE and other cisacting elements that coincides with transcriptional activation of the promoter (7,17,37,38). Ligand-dependent occupancy of the RAR2 promoter has been recently confirmed by others in NB4 cells (16). In contrast, in vitro the RXR-RAR heterodimer can bind to the RARE in the absence of ligand. Binding of the heterodimer to DNA in vitro has been demonstrated even in the presence of corepressors, such as N-CoR, RIP13, and SMRT (15, 24). The striking differences observed between in vitro and in vivo studies suggest that accessibility of transcription factors to the promoter in vivo is governed by a mechanism that is not readily reconstituted in vitro and which may involve regulation by chromatin.It has been shown that chromatin structure plays an important role in gene activation (1,29,33,45,57,60). Several hormone-responsive promoters have been shown to undergo chromatin structure alterations following hormone addition.For example, a glucocorticoid-hormone-dependent alteration of nucleosomal positioning as well as a hormone-dependent DNase I hypersensitivity site has been observed for the rat tyros...